- Lv JC, Zhang LX. Prevalence and disease burden of chronic kidney disease. Adv Exp Med Biol. 2019;1165:3–15. doi:10.1007/978-981-13-8871-2_1.
- Centers for Disease Control and Prevention. Chronic Kidney Disease in the United States. 2021. Accessed February 18, 2023. https://www.cdc.gov/kidneydisease/pdf/Chronic-Kidney-Disease-in-the-US-2021-h.pdf.
- National Institute of Diabetes and Digestive and Kidney Diseases. Kidney disease statistics for the United States. 2021. Accessed February 22, 2023. https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease.
- Stack AG, Johnson ME, Blak B, et al. Gout and the risk of advanced chronic kidney disease in the UK health system: a national cohort study. BMJ Open. 2019;9(8):e031550. doi:10.1136/bmjopen-2019-031550.
- Singh JA, Cleveland JD. Gout is associated with a higher risk of chronic renal disease in older adults: a retrospective cohort study of U.S. Medicare population. BMC Nephrol. 2019;20(1):93. doi:10.1186/s12882-019-1274-5.
- Siedner MJ, Christopher-Stine L, Astor BC, Gelber AC, Fine DM. Screening for proteinuria in patients with lupus: a survey of practice preferences among American rheumatologists. J Rheumatol. 2007;34(5):973–977.
- Choi HS, Han KD, Jung JH, et al. The risk of end-stage renal disease in systemic lupus erythematosus: a nationwide population-based study in Korea. Medicine (Baltimore). 2019;98(28):e16420. doi:10.1097/MD.0000000000016420.
- Huang HL, Ho SY, Li CH, et al. Bronchial asthma is associated with increased risk of chronic kidney disease. BMC Pulm Med. 2014;14:80. doi:10.1186/1471-2466-14-80.
- Sorey MR. Gout management in patients with CKD. Clinical Advisor. 2013. Accessed February 7, 2023. https://www.clinicaladvisor.com/home/features/gout-management-%E2%80%A8in-patients-with-ckd/.
- Kronbichler A, Mayer G. Renal involvement in autoimmune connective tissue diseases. BMC Med. 2013;11:95. doi:10.1186/1741-7015-11-95.
- Combs SA, Teixeira JP, Germain MJ. Pruritus in kidney disease. Semin Nephrol. 2015;35(4):383–391. doi:10.1016/j.semnephrol.2015.06.009.
- Schmidt IM, Hübner S, Nadal J, et al. Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study. Clin Kidney J. 2019;12(5):663–672. doi:10.1093/ckj/sfz046.
- Walker J, Wynne H. Review: the frequency and severity of adverse drug reactions in elderly people. Age Ageing. 1994;23(3):255–259. doi:10.1093/ageing/23.3.255.
- Kwiatkowska E, Domański L, Dziedziejko V, Kajdy A, Stefańska K, Kwiatkowski S. The mechanism of drug nephrotoxicity and the methods for preventing kidney damage. Int J Mol Sci. 2021;22(11):6109. doi:10.3390/ijms22116109.
- Sommer J, Seeling A, Rupprecht H. Adverse drug events in patients with chronic kidney disease associated with multiple drug interactions and polypharmacy. Drugs Aging. 2020;37(5):359–372. doi:10.1007/s40266-020-00747-0.
- Slight SP, Seger DL, Franz C, Wong A, Bates DW. The national cost of adverse drug events resulting from inappropriate medication-related alert overrides in the United States. J Am Med Inform Assoc. 2018;25(9):1183–1188. doi:10.1093/jamia/ocy066.
- Formica D, Sultana J, Cutroneo PM, et al. The economic burden of preventable adverse drug reactions: a systematic review of observational studies. Expert Opin Drug Saf. 2018;17(7):681–695. doi:10.1080/14740338.2018.1491547.
- Garneau KL, Iversen MD, Tsao H, Solomon DH. Primary care physicians’ perspectives towards managing rheumatoid arthritis: room for improvement. Arthritis Res Ther. 2011;13(6):R189. doi:10.1186/ar3517.
- Flokstra-de Blok BM, van der Molen T, Christoffers WA, et al. Development of an allergy management support system in primary care. J Asthma Allergy. 2017;10:57–65. doi:10.2147/JAA.S123260.
- Owens D, Whelan B, McCarthy G. A survey of the management of gout in primary care. Ir Med J. 2018;101(5):147–149.
- Rui P, Okeyode T. National Ambulatory Medical Care Survey: 2016 National Summary Tables. CDC. 2016. Accessed January 24, 2023. https://www.cdc.gov/nchs/data/ahcd/namcs_summary/2016_namcs_web_tables.pdf.
- Munar MY, Singh H. Drug dosing adjustments in patients with chronic kidney disease. Am Fam Physician. 2007;75(10):1487–1496.
- Pillans PI, Landsberg PG, Fleming AM, Fanning M, Sturtevant JM. Evaluation of dosage adjustment in patients with renal impairment. Intern Med J. 2003;33:10–13. doi:10.1046/j.1445-5994.2003.00330.x.
- O'Rourke P, Tseng E, Levine R, Shalaby M, Wright S. The current state of US internal medicine primary care training. Am J Med. 2016;129(9):1006–1014. doi:10.1016/j.amjmed.2016.05.006.
- Physicians Desk Reference 2019. Montvale, NJ: PDR Network; 2018.
- UpToDate. Drug information. Accessed December 19, 2022. http://www.uptodate.com.
- Banerji A, Long AA, Camargo CA Jr. Diphenhydramine versus nonsedating antihistamines for acute allergic reactions: a literature review. Allergy Asthma Proc. 2007;28(4):418–426. doi:10.2500/aap.2007.28.3015.
- Prime Therapeutics. High risk medications for elderly members. Accessed January 15, 2023. https://www.primetherapeutics.com/wp-content/uploads/2021/09/HighRiskMedicationsforElderly9.16.14.pdf.
- Thurston MM, Phillips BB, Bourg CA. Safety and efficacy of allopurinol in chronic kidney disease. Ann Pharmacother. 2013;47(11):1507–1516. doi:10.1177/1060028013504740.
- Medani S, Wall C. Colchicine toxicity in renal patients—are we paying attention? Clin Nephrol. 2016;86(2):100–105. doi:10.5414/CN108343.
- Ajemigbitse AA, Omole MK, Ezike NC, Erhun WO. Assessment of the knowledge and attitudes of intern doctors to medication prescribing errors in a Nigeria tertiary hospital. J Basic Clin Pharm. 2013;5(1):7–14. doi:10.4103/0976-0105.128244.
- Nasca TJ, Philibert I, Brigham T, Flynn TC. The next GME accreditation system—rationale and benefits. N Engl J Med. 2012;366(11):1051–1056. doi:10.1056/NEJMsr1200117.
- Eno C, Correa R, Stewart NH, et al. Milestones guidebook for residents and fellows. Accreditation Council for Graduate Medical Education. 2020. Accessed December 20, 2022. https://www.acgme.org/globalassets/PDFs/Milestones/MilestonesGuidebookforResidentsFellows.pdf.
- Panginikkod S, Raja A, Rajabirostami E, Habibi R, Hashim R, Matin Afridi S, Altamirano Ufion A, Pararath Gopalakrishnan V. A survey on gout-related knowledge among internal medicine residents [abstract]. Arthritis Rheumatol. 2018;70(Suppl 9). https://acrabstracts.org/abstract/a-survey-on-gout-related-knowledge-among-internal-medicine-residents/.
- Pacher P, Nivorozhkin A, Szabó C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev. 2006;58(1):87–114. doi:10.1124/pr.58.1.6.
- Tintinger GR, Feldman C, Theron AJ, Anderson R. Montelukast: more than a cysteinyl leukotriene receptor antagonist? ScientificWorldJournal. 2010;10:2403–2413. doi:10.1100/tsw.2010.229.
- Candler C, Ihnat M, Huang G. Pharmacology education in undergraduate and graduate medical education in the United States. Clin Pharmacol Ther. 2007;82(2):134–137. doi:10.1038/sj.clpt.6100266.
- Chen YY, Li CM, Liang JC, Tsai CC. Health information obtained from the internet and changes in medical decision making: questionnaire development and cross-sectional survey. J Med Internet Res. 2018;20(2):e47. doi:10.2196/jmir.9370.
- Pew Research Center: Internet, Science & Tech. Health topics. Accessed January 12, 2023. https://www.pewresearch.org/internet/2011/02/01/health-topics-4/.
- Google/Manhattan Research. Screen to script: the doctor’s digital path to treatment. 2012. Accessed December 21, 2022. https://www.thinkwithgoogle.com/marketing-strategies/search/the-doctors-digital-path-to-treatment/.
- Wolters Kluwer. Survey: consumers show high degree of trust in online health information, report success in self-diagnosis. Accessed January 14, 2023. https://www.prnewswire.com/news-releases/survey-consumers-show-high-degree-of-trust-in-online-health-information-report-success-in-self-diagnosis-151691755.html.
- National Institute on Aging. Online health information: is it reliable? 2018. Accessed December 28, 2022. https://order.nia.nih.gov/sites/default/files/2018-11/online-health-information.pdf.
- De Martinis M, Sirufo MM, Suppa M, Di Silvestre D, Ginaldi L. Sex and gender aspects for patient stratification in allergy prevention and treatment. Int J Mol Sci. 2020;21(4):1535. doi:10.3390/ijms21041535.
- Thompson AE, Anisimowicz Y, Miedema B, Hogg W, Wodchis WP, Aubrey-Bassler K. The influence of gender and other patient characteristics on health care-seeking behaviour: a QUALICOPC study. BMC Fam Pract. 2016;17:38. doi:10.1186/s12875-016-0440-0.
- Tsugawa Y, Jena AB, Figueroa JF, Orav EJ, Blumenthal DM, Jha AK. Comparison of hospital mortality and readmission rates for medicare patients treated by male vs female physicians. JAMA Intern Med. 2017; 177(2):206–213. doi:10.1001/jamainternmed.2016.7875.
- Sharma N, Chakrabarti S, Grover S. Gender differences in caregiving among family-caregivers of people with mental illnesses. World J Psychiatry. 2016;6(1):7–17. doi:10.5498/wjp.v6.i1.7.
- Accreditation Council for Graduate Medical Education. ACGME Data Resource Book, Academic Year 2021–2022. Chicago, IL: ACGME; 2022.
- Ellaway RH, Fink P, Graves L, Campbell A. Left to their own devices: medical learners’ use of mobile technologies. Med Teach. 2014;36(2):130–138. doi:10.3109/0142159X.2013.849800.
- Sperati CJ, Soman S, Agrawal V, et al. Primary care physicians’ perceptions of barriers and facilitators to management of chronic kidney disease: a mixed methods study. PLoS One. 2019;14(8):e0221325. doi:10.1371/journal.pone.0221325.
- Surana S, Kumar N, Vasudeva A, et al. Awareness and knowledge among internal medicine house-staff for dose adjustment of commonly used medications in patients with CKD. BMC Nephrol. 2017;18(1):26. doi:10.1186/s12882-017-0443-7.
Dose adjustment of rheumatology and allergy/immunology medications in chronic kidney disease: awareness and knowledge among internal medicine housestaff
https://orcid.org/0000-0002-4805-9736
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.